Well, that review sure is convenient timing for Newman. I don't rate him at all. He's been CEO since what, late 2015? And he's still blaming the ex Exec Team? What a joke!
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game